Allergy Diagnostic Market worth $10.77 billion by 2031
The report "Allergy Diagnostic Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031" is projected to grow from USD 6.80 billion in 2026 and to reach USD 10.77 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.6% during the forecast period.
Browse 250 market data Tables and 100 Figures spread through 300 Pages and in-depth TOC on "Allergy Diagnostic Market by Product & Service (Consumables, Instruments [Immunoassay Analyzers, Luminometers]), Test Type (In Vivo Tests, In Vitro Tests), Allergen (Food Allergens), End User (Hospital-Based Laboratories) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html
Cancer incidence, particularly colorectal, gastric, and esophageal cancers, in the Asia Pacific region has been rising due to aging populations, dietary changes, and lifestyle factors. Surgery remains a primary treatment option for these cancers, increasing demand for circular and linear staplers used in resections and anastomosis.
Similarly, growing obesity rates in countries such as China, India, and Australia are leading to higher volumes of bariatric surgeries. These procedures require multiple stapler firings, which significantly increase the number of staplers used and reloads per procedure. Together, the growth in cancer and bariatric surgeries is creating strong demand for advanced, tissue-specific stapling systems across the Asia Pacific region.
This report categorizes the allergy diagnostic market based on product & service, test type, allergen, end user, and region.
“Consumables accounted for largest share of allergy diagnostic market in 2025.”
The inherent characteristics of allergy diagnostic consumables significantly contribute to their high market share. Most consumables, including reagents, allergen extracts, test strips, and assay cartridges, are designed for single use to ensure diagnostic accuracy and prevent cross-contamination. In addition, many reagents have limited shelf lives and require controlled storage conditions, necessitating frequent replenishment by laboratories. These factors create a steady replacement cycle that drives recurring sales volumes. Unlike instruments, which can be used for several years, consumables generate continuous purchasing requirements regardless of testing volume fluctuations. This structural dependency on consumables for daily laboratory operations ensures predictable revenue streams for manufacturers and reinforces their dominant contribution to the overall allergy diagnostic market.
“In vitro test type accounted for the majority of market share in 2025.”
In vivo testing allows clinicians to assess patient sensitivity to multiple allergens simultaneously during a single clinical visit. Standard skin-prick panels can include dozens of allergens, such as pollens, dust mites, molds, animal dander, and foods. This broad coverage improves diagnostic efficiency and reduces the need for repeat testing. The ability to rapidly screen multiple allergens is particularly valuable in patients with complex or unclear allergy histories. This diagnostic comprehensiveness drives clinician preference and increases test volumes, reinforcing the strong market position of in vivo tests.
“Asia Pacific to exhibit the highest growth rate in the allergy diagnostic market during the forecast period.”
Asia Pacific is witnessing a sharp rise in allergic conditions such as allergic rhinitis, asthma, food allergies, and atopic dermatitis. Rapid urbanization, changing dietary habits, increased exposure to environmental pollutants, and sedentary lifestyles are key contributors. Large population bases in countries such as China and India amplify the absolute number of allergy patients, creating a substantial unmet diagnostic need. As allergy symptoms often overlap with other respiratory or dermatological conditions, demand for confirmatory diagnostic testing is increasing, directly supporting strong growth in allergy diagnostics across the region.
Key Market Players:
Key players in this market are adopting various organic and inorganic growth strategies, including product launches, agreements, collaborations, acquisitions, and expansions. Prominent players in this market include Thermo Fisher Scientific Inc. (US), Siemens Healthineers AG (Germany), Danaher Corporation (US), Minaris Medical America, Inc. (US), Omega Diagnostics Group Plc (UK), bioMérieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (Germany), HollisterStier Allergy (US), Eurofins Scientific (Luxembourg), Stallergenes Greer (UK), HOB Biotech Group Corp., Ltd. (China), HYCOR Biomedical (US), R-Biopharm AG (Germany), AESKU.GROUP GmbH (Germany), ACON Laboratories, Inc. (US), Lincoln Diagnostics, Inc. (US), Astra Biotech GmbH (Germany), Erba Group (UK), Alcit India Pvt. Ltd. (India), Biopanda Reagents (UK), Bioside S.r.l. (Italy), Creative Diagnostic Medicare Pvt. Ltd. (India), DST Diagnostische Systeme & Technologien GmbH (Germany), and Dr. Fooke Laboratorien GmbH (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Allergy Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
